Regulation / Healthcare Regulatory
Companies operating in the life sciences sector, whether well-established global corporations or early-stage startups, face a highly regulated environment and complex legal challenges. Failure to properly implement regulatory requirements can prolong and increase the costs of market entry, impact return on investment, expose companies to legal risks, and even affect patient safety and health.
Our firm provides comprehensive legal services to Israeli companies and international corporations operating in Israel across the pharmaceutical, biotechnology, medical device, diagnostics, research and development, and imaging industries. The regulatory landscape in this sector is complex and constantly evolving, directly impacting companies at every stage—from development to marketing and distribution.
Our legal counsel covers all relevant regulatory matters, including intellectual property protection and strategy development, privacy and data protection issues, cross-border knowledge transfer, and consumer protection laws. Additionally, we assist companies in adapting to and implementing regulatory changes and represent them before authorities when necessary.
Furthermore, our firm offers ongoing legal support to life sciences companies on matters related to product development, registration and licensing, grant applications, distribution, and commercialization.
Adv. Efrat Cohen, a senior partner in the department, has extensive experience representing pharmaceutical companies, medical device firms, and medical institutions—both local and international—in complex regulatory proceedings before government ministries, Knesset committees, and regulatory authorities. Her expertise includes licensing, budgeting, price regulation, registration of medical products, drafting regulations and new legislation, as well as contracts and commercial engagements.
Insights & News - Regulation / Healthcare Regulatory:
Drug registration reform in Israel: processes are being streamlined and timeframes shortened to increase supply and lower prices
Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog
Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million
Regulation / Healthcare Regulatory
Companies operating in the life sciences sector, whether well-established global corporations or early-stage startups, face a highly regulated environment and complex legal challenges. Failure to properly implement regulatory requirements can prolong and increase the costs of market entry, impact return on investment, expose companies to legal risks, and even affect patient safety and health.
Our firm provides comprehensive legal services to Israeli companies and international corporations operating in Israel across the pharmaceutical, biotechnology, medical device, diagnostics, research and development, and imaging industries. The regulatory landscape in this sector is complex and constantly evolving, directly impacting companies at every stage—from development to marketing and distribution.
Our legal counsel covers all relevant regulatory matters, including intellectual property protection and strategy development, privacy and data protection issues, cross-border knowledge transfer, and consumer protection laws. Additionally, we assist companies in adapting to and implementing regulatory changes and represent them before authorities when necessary.
Furthermore, our firm offers ongoing legal support to life sciences companies on matters related to product development, registration and licensing, grant applications, distribution, and commercialization.
Adv. Efrat Cohen, a senior partner in the department, has extensive experience representing pharmaceutical companies, medical device firms, and medical institutions—both local and international—in complex regulatory proceedings before government ministries, Knesset committees, and regulatory authorities. Her expertise includes licensing, budgeting, price regulation, registration of medical products, drafting regulations and new legislation, as well as contracts and commercial engagements.